Technology
Eli Lilly’s $2.875 Billion Merida Deal Extends Big Pharma’s Biotech M&A Push
Eli Lilly’s up-to-$2.875 billion cash acquisition of Merida Biosciences signals continued biotech deal appetite and could reshape sentiment toward mid-cap targets.
Sarah Chen • August 31, 2026
Markets
Aon’s $17 Billion USI Acquisition Puts Insurance Brokerage Consolidation in Focus
Aon’s $17 billion cash purchase of USI from KKR puts integration costs, synergies and insurance brokerage consolidation …
James McAllister • Aug 31
Analysis
GFL Environmental Shares Rise as Secure Waste Closing Nears
GFL Environmental gained after reports of progress in its sale process, with the Secure Waste transaction scheduled to c…
Marcus Rivera • Aug 30
Earnings
Salesforce, CrowdStrike and Nvidia Beats Strengthen the Case for a Broader AI Rally
Salesforce, CrowdStrike and Nvidia beat expectations, supporting a broader AI thesis while Nvidia’s short-term weakness …
Sarah Chen • Aug 30
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Economy
Warsh Keeps September Rate Hike in Play as VIX Hits 2026 Low
James McAllister • Aug 30, 2026
Analysis
GFL Environmental Gains as Sale Process Advances Ahead of Secure Waste Closing
Marcus Rivera • Aug 29, 2026
Technology
Apple Raises Apple TV+ and Apple One Prices as Services Growth Takes Center Stage
Sarah Chen • Aug 29, 2026
Markets
VIX Falls to 14.1 as Traders Embrace Warsh — but Inflation Concerns Weigh on Stocks
James McAllister • Aug 29, 2026
Technology
Big Tech’s AI Spending Surge Puts Its Free-Cash-Flow Advantage Under Pressure
Marcus Rivera • Aug 28, 2026
Earnings
Marvell Stock Slides 8% Despite Earnings Beat as Investors Question Google AI Revenue Timing
Sarah Chen • Aug 28, 2026